DNA testing
23andMe to Fund Sickle Cell Carrier Awareness Program With DNA Testing, Reporting
Working with nonprofit Sickle Cell 101, 23andMe will provide testing and status reports to African Americans, building on an earlier Georgia collaboration.
Massive Bio, Perthera Partner on Biomarker-Based Clinical Trial Matching
The firms will use their respective artificial intelligence and informatics platforms to identify precision oncology trials for patients based on multiomic testing.
Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics
The study will compare whole-genome sequencing and RNA sequencing to conventional diagnostic methods in about 450 acute leukemia patients in Sweden.
A juvenile leukemia patient with a rare FLT3 fusion was treated with precision therapy after researchers used a DNA panel and RNA-seq to analyze his disease.